TREATMENT OF HYPERPROLACTINEMIA WITH METERGOLINE FOR PERIODS UP TO 5 YEARS - CLINICAL AND BIOLOGICAL TOLERABILITY

被引:3
作者
FALSETTI, L
VOLTOLINI, AM
SCHIMBERNI, M
PONTIROLI, AE
机构
[1] UNIV MILAN,MED CLIN 8,I-20133 MILAN,ITALY
[2] SPEDALI CIVILI,BRESCIA,ITALY
[3] OSPED SAN RAFFAELE,MILAN,ITALY
[4] UNIV ROME,MED CLIN 6,I-00100 ROME,ITALY
关键词
D O I
10.1185/03007998309112392
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:327 / 332
页数:6
相关论文
共 14 条
[1]   CLINICAL-RESPONSE OF PATIENTS WITH GALACTORRHEA TO PERGOLIDE, A POTENT, LONG-ACTING DOPAMINERGIC ERGOT DERIVATIVE [J].
CALLAGHAN, JT ;
CLEARY, RE ;
CRABTREE, R ;
LEMBERGER, L .
LIFE SCIENCES, 1981, 28 (01) :95-102
[2]  
DECECCO L, 1978, CLIN ENDOCRINOL, V9, P491
[3]   SILENT RETROPERITONEAL FIBROSIS ASSOCIATED WITH METHYSERGIDE THERAPY [J].
ELKIND, AH ;
FRIEDMAN, AP ;
BACHMAN, A ;
SIEGELMAN, SS ;
SACKS, OW .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1968, 206 (05) :1041-+
[4]   METERGOLINE IN THE MANAGEMENT OF HYPERPROLACTINEMIC AMENORRHEA AND ANOVULATION [J].
FALSETTI, L ;
VOLTOLINI, AM ;
CROSIGNANI, PG ;
LOTTI, G ;
TRAVAGLINI, P ;
FAGLIA, G ;
CIANCI, A ;
PALUMBO, G ;
PRAGA, C ;
PONTIROLI, AE .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1982, 13 (02) :108-116
[5]  
FALSETTI L, 1978, ATTI ACAD MED LOMBAR, V33, P3
[6]  
FALSETTI L, 1982, J ENDOCRINOL INVE S1, V5, P65
[7]   ENDOCRINE PROFILE AND THERAPEUTIC EMPLOYMENT OF A NEW PROLACTIN-LOWERING DRUG, METERGOLINE [J].
FERRARI, C ;
RESCHINI, E ;
PERACCHI, M ;
CROSIGNANI, PG .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1980, 11 (01) :1-16
[8]   THE MANAGEMENT OF PROLACTIN-SECRETING PITUITARY-TUMORS [J].
GEORGE, SR ;
BURROW, GN .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1981, 4 (04) :459-467
[10]   CARDIAC EFFECTS OF PERGOLIDE [J].
LEIBOWITZ, M ;
LIEBERMAN, A ;
GOLDSTEIN, M ;
NEOPHYTIDES, A ;
KUPERSMITH, M ;
GOPINATHAN, G ;
MEHL, S .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (06) :718-723